Acquisition Equity Research San Diego 
socalTECH
JANUARY 3, 2018
San Diego-based Maravai LifeSciences announced this morning that it is acquiring Glen Research Corporation , a Sterling, Virginia-based provider of reagents used in the synthesis of DNA and RNA. Financial details of the acquisition were not announced. READ MORE>>.
socalTECH
SEPTEMBER 14, 2021
San Diego-based scientific and laboratory software maker Insightful Science announced this morning that it has acquired De Novo Software, the maker of FCS Express, flow cytometry data analysis software. Insightful Science is privately held, and is a portfolio company of private equity investor Insight Partners.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
socalTECH
JANUARY 29, 2019
San Diego-based BioDuro , a life sciences contract research and development organization, has been acquired by private equity investor Advent International , the companies said over the weekend. Financial details of the majority, strategic investment in BioDuro were not announced. READ MORE>>.
socalTECH
JULY 29, 2014
According to PaxVax, the new equity funding brings its total to $80M in equity raised by the company. The new funding goes towards the acquisition of an FDA-approved oral typhoid vaccine, plus further clinical development efforts. The company is backed by Ignition Ventures, Ignition Growth Capital and the Blue Haven Initiative.
socalTECH
DECEMBER 30, 2016
Here, we have the thoughts of Jeb Spencer of TVC Capital (www.tvccapital.com), a software focused growth equity fund, and has had some great success in the market. Jeb Spencer: We closed our nineteenth and twentieth software focused growth equity investments this year, a significant milestone for our firm. READ MORE>>.
TechCrunch LA
MARCH 22, 2018
Our research revealed a saturation level causing unprecedented challenges, starting with exorbitant housing prices and runaway operating costs that accelerate a startup’s “burn rate”—its monthly spending. In fact, as is well-reported, the luster of Silicon Valley is fading.
Xconomy
JANUARY 7, 2020
When a group of scientists from Amira Pharmaceuticals wanted to start a new biotech after the company’s 2011 acquisition by Bristol-Myers Squibb , Celgene provided seed funding. Eventually Celgene kicked in $35 million more for a research collaboration, an equity stake, and an exclusive option to acquire the startup, PharmAkea Therapeutics.
Expert insights. Personalized for you.
113 
Let's personalize your content